-
公开(公告)号:US5962496A
公开(公告)日:1999-10-05
申请号:US86522
申请日:1998-05-29
IPC分类号: A61K31/395 , A61K31/40 , A61K31/415 , A61K31/42 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/475 , A61K31/50 , A61P25/00 , A61P43/00 , C07D401/06 , C07D401/14 , C07D403/06 , C07D413/06 , C07D413/14 , C07D231/04
CPC分类号: C07D401/06 , C07D401/14 , C07D403/06 , C07D413/06 , Y02P20/55
摘要: This invention relates to compounds of formula ##STR1## or a salt, or metabolically labile ester thereof wherein R represents a group selected from halogen, alkyl, alkoxy, amino, alkylamino, dialkylamino, hydroxy, trifluoromethyl, trifluoromethoxy, nitro, cyano, SO.sub.2 R.sub.2 or COR.sub.2 wherein R.sub.2 represents hydroxy, methoxy, amino, alkylamino, or dialkylamino; m is zero or an integer 1 or 2;R.sub.1 represents a cycloalkyl, bridged cycloalkyl, heteroaryl, bridged heterocyclic or optionally substituted phenyl or fused bicyclic carbocylic group;A represents a C.sub.1-4 alkylene chain or the chain (CH.sub.2).sub.p Y(CH.sub.2).sub.q wherein Y is O, S(O)n or NR.sub.3 and which chains may be substituted by one or two groups selected from C.sub.1-6 alkyl optionally substituted by hydroxy, amino, alkylamino or dialkylamino, or which chains may be substituted by the group=O;R.sub.3 represents hydrogen, alkyl or a nitrogen protecting group;n is zero or an integer from 1 to 2;p is zero or an integer from 1 to 3;q is zero or an integer from 1 to 3 with the proviso that the sum of p+q is 1, 2 or 3, which are antagonists of excitatory amino acids, to processes for the preparation and to other use in medicine.
摘要翻译: 本发明涉及式或其盐或其代谢不稳定酯的化合物,其中R表示选自卤素,烷基,烷氧基,氨基,烷基氨基,二烷基氨基,羟基,三氟甲基,三氟甲氧基,硝基,氰基,SO 2 R 2或COR 2的基团,其中R 2 表示羟基,甲氧基,氨基,烷基氨基或二烷基氨基; m为零或整数1或2; R 1表示环烷基,桥连环烷基,杂芳基,桥连杂环或任选取代的苯基或稠合双环碳酰基; A表示C 1-4亚烷基链或链(CH 2)p Y(CH 2)q,其中Y是O,S(O)n或NR 3,哪些链可以被选自任选被羟基取代的C 1-6烷基中的一个或两个基团取代 ,氨基,烷基氨基或二烷基氨基,或哪些链可以被基团= O取代; R3表示氢,烷基或氮保护基; n为0或1至2的整数; p为0或1至3的整数; q为0或1至3的整数,条件是p + q的和为1,2或3,它们是兴奋性氨基酸的拮抗剂,用于制备和在医药中的其它用途。
-
公开(公告)号:US6100289A
公开(公告)日:2000-08-08
申请号:US374982
申请日:1999-08-16
IPC分类号: A61K31/395 , A61K31/40 , A61K31/415 , A61K31/42 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/475 , A61K31/50 , A61P25/00 , A61P43/00 , C07D401/06 , C07D401/14 , C07D403/06 , C07D413/06 , C07D413/14
CPC分类号: C07D401/06 , C07D401/14 , C07D403/06 , C07D413/06 , Y02P20/55
摘要: This invention relates to compounds of formula ##STR1## or a salt, or metabolically labile ester thereof wherein R represents a group selected from halogen, alkyl, alkoxy, amino, alkylamino, dialkylamino, hydroxy, trifluoromethyl, trifluoromethoxy, nitro, cyano, SO.sub.2 R.sub.2 or COR.sub.2 where R.sub.2 represents hydroxy, methoxy, amino, alkylamino, or dialkylamino; m is zero or an integer 1 or 2;R.sub.1 represents a cycloalkyl, bridged cycloalkyl, heteroaryl, bridged heterocyclic or optionally substituted phenyl or fused bicyclic carbocylic group;A represents a C.sub.1-4 alkylene chain or the chain (CH.sub.2).sub.p Y(CH.sub.2).sub.q wherein Y is O, S(O)n or NR.sub.3 and which chains may be substituted by one or two groups selected from C.sub.1-6 alkyl optionally substituted by hydroxy, amino, alkylamino or dialkylamino, or which chains may be substituted by the group .dbd.O;R.sub.3 represents hydrogen, alkyl or a nitrogen protecting group;n is zero or an integer from 1 to 2;p is zero or an integer from 1 to 3;q is zero or an integer from 1 to 3 with the proviso that the sum of p+q is 1, 2 or 3, which are antagonists of excitatory amino acids, to processes for the preparation and to other use in medicine.
摘要翻译: 本发明涉及式或其盐或其代谢不稳定酯的化合物,其中R表示选自卤素,烷基,烷氧基,氨基,烷基氨基,二烷基氨基,羟基,三氟甲基,三氟甲氧基,硝基,氰基,SO2R2或COR2的基团,其中R2 表示羟基,甲氧基,氨基,烷基氨基或二烷基氨基; m为零或整数1或2; R 1表示环烷基,桥连环烷基,杂芳基,桥连杂环或任选取代的苯基或稠合双环碳酰基; A表示C 1-4亚烷基链或链(CH 2)p Y(CH 2)q,其中Y是O,S(O)n或NR 3,哪些链可以被选自任选被羟基取代的C 1-6烷基中的一个或两个基团取代 ,氨基,烷基氨基或二烷基氨基,或哪些链可以被基团= O取代; R3表示氢,烷基或氮保护基; n为0或1至2的整数; p为0或1至3的整数; q为0或1至3的整数,条件是p + q的和为1,2或3,它们是兴奋性氨基酸的拮抗剂,用于制备和在医药中的其它用途。
-
公开(公告)号:US5760059A
公开(公告)日:1998-06-02
申请号:US619510
申请日:1996-03-29
IPC分类号: A61K31/395 , A61K31/40 , A61K31/415 , A61K31/42 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/475 , A61K31/50 , A61P25/00 , A61P43/00 , C07D401/06 , C07D401/14 , C07D403/06 , C07D413/06 , C07D413/14
CPC分类号: C07D401/06 , C07D401/14 , C07D403/06 , C07D413/06 , Y02P20/55
摘要: This invention relates to compounds of formula ##STR1## or a salt, or metabolically labile ester thereof wherein R represents a group selected from halogen, alkyl, alkoxy, amino, alkylamino, dialkylamino, hydroxy, trifluoromethyl, trifluoromethoxy, nitro, cyano, SO.sub.2 R.sub.2 or COR.sub.2 wherein R.sub.2 represents hydroxy, methoxy, amino, alkylamino, or dialkylamino; m is zero or an integer 1 or 2; R.sub.1 represents a cycloalkyl, bridged cycloalkyl, heteroaryl, bridged heterocyclic or optionally substituted phenyl or fused bicyclic carbocylic group; A represents a C.sub.1-4 alkylene chain or the chain (CH.sub.2).sub.p Y(CH.sub.2).sub.q wherein Y is O, S(O)n or NR.sub.3 and which chains may be substituted by one or two groups selected from C.sub.1-6 alkyl optionally substituted by hydroxy, amino, alkylamino or dialkylamino, or which chains may be substituted by the group .dbd.O; R.sub.3 represents hydrogen, alkyl or a nitrogen protecting group; n is zero or an integer from 1 to 2; p is zero or an integer from 1 to 3; q is zero or an integer from 1 to 3 with the proviso that the sum of p+q is 1, 2 or 3, which are antagonists of excitatory amino acids, to processes for the preparation and to other use in medicine.
摘要翻译: PCT No.PCT / EP94 / 03359 371日期:1996年3月29日 102(e)1996年3月29日PCT 1994年10月12日PCT PCT。 出版物WO95 / 10517 日期1995年4月20日本发明涉及式(I)化合物或其盐或其代谢不稳定的酯,其中R表示选自卤素,烷基,烷氧基,氨基,烷基氨基,二烷基氨基,羟基,三氟甲基, 三氟甲氧基,硝基,氰基,SO2R2或COR2,其中R2表示羟基,甲氧基,氨基,烷基氨基或二烷基氨基; m为零或整数1或2; R 1表示环烷基,桥连环烷基,杂芳基,桥连杂环或任选取代的苯基或稠合双环碳酰基; A表示C 1-4亚烷基链或链(CH 2)p Y(CH 2)q,其中Y是O,S(O)n或NR 3,哪些链可以被选自任选被羟基取代的C 1-6烷基中的一个或两个基团取代 ,氨基,烷基氨基或二烷基氨基,或哪些链可以被基团= O取代; R3表示氢,烷基或氮保护基; n为0或1至2的整数; p为0或1至3的整数; q为0或1至3的整数,条件是p + q的和为1,2或3,它们是兴奋性氨基酸的拮抗剂,用于制备和在医药中的其它用途。
-
公开(公告)号:US5486514A
公开(公告)日:1996-01-23
申请号:US256358
申请日:1994-07-20
IPC分类号: A61K31/55 , A61P1/04 , A61P25/00 , C07D243/12
CPC分类号: C07D243/12
摘要: The present invention relates to compound of formula (I) which are antagonists of gastrin and CCK-B receptors. The compounds of formula (I) are carbamate derivatives. ##STR1##
摘要翻译: PCT No.PCT / EP93 / 00099 Sec。 371日期:1994年7月20日 102(e)日期1994年7月20日PCT提交1993年1月15日PCT公布。 WO93 / 14075 PCT出版物 日期:1993年7月22日。本发明涉及作为胃泌素和CCK-B受体拮抗剂的式(I)化合物。 式(I)化合物是氨基甲酸酯衍生物。 (一)
-
公开(公告)号:US5196528A
公开(公告)日:1993-03-23
申请号:US729146
申请日:1991-07-12
IPC分类号: A61K31/40 , A61K31/397 , A61P31/04 , C07D205/08 , C07D205/085 , C07D405/04 , C07D477/00
CPC分类号: C07D405/04 , C07D205/085 , Y02P20/55
摘要: Compounds of formula ##STR1## in which R.sub.1 is hydrogen or a hydroxyl protecting group and --X--Y-- is --CH.dbd.CH-- or ##STR2## useful as intermediates in the preparation of antibacterially active compounds.
-
公开(公告)号:US5693634A
公开(公告)日:1997-12-02
申请号:US635976
申请日:1996-05-09
IPC分类号: A61K31/397 , A61K31/40 , A61P31/04 , C07D477/00 , A61K31/395
CPC分类号: C07D477/00
摘要: The present invention relates to compounds of formula (I) ##STR1## and salts and metabolically labile esters thereof. These compounds and compositions containing them have antibacterial activity. Processes for preparing these compounds are also disclosed, as well as methods of treatment of a human or non-human subject to combat bacterial infections.
摘要翻译: PCT No.PCT / EP94 / 03686 Sec。 371日期:1996年5月9日 102(e)日期1996年5月9日PCT 1994年11月9日PCT公布。 出版物WO95 / 13278 日期:1995年5月18日本发明涉及式(I)化合物及其盐和代谢不稳定酯。 这些含有它们的化合物和组合物具有抗菌活性。 还公开了制备这些化合物的方法,以及治疗人或非人受试者以抵抗细菌感染的方法。
-
-
-
-
-